Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Strategic Asset Allocation Index
Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Strategic Asset Allocation Index of 26.4% as of September 2024. Strategic assets (PP&E of $- plus long-term investments of $52.97 Million) total $52.97 Million, measured against net assets of $201.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ARTV net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Artiva Biotherapeutics, Inc. Common Stock (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Artiva Biotherapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Artiva Biotherapeutics, Inc. Common Stoc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|